Abstract
The demographic shift towards an older population [1] and urbanization with subsequent change in diet and physical activity patterns [2] are resulting in rise of chronic noncommunicable diseases across the world. A majority of patients suffering from diabetes and hypertension—primary risk factors for development of chronic kidney disease (CKD)—now reside in economically developing nations [3, 4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Department of Economic and Social Affairs. World population ageing 2009. New York: United Nations; 2009.
Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70(1):3–21.
Wild S, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.
Kearney PM, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.
Coresh J, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.
Hallan SI, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17(8):2275–84.
Hsu CC, et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006;48(5):727–38.
Stevens PE, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007;72(1):92–9.
Imai E, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11(2):156–63.
Chadban SJ, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol. 2003;14(7 Suppl 2):S131–8.
Chen J, et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int. 2005;68(6):2837–45.
Zhang L, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51(3):373–84.
Ingsathit A, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010;25(5):1567–75.
Escobar C, et al. Renal health in Chile. Ren Fail. 2006;28(8):639–41.
Amato D, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl. 2005;97:S11–7.
Sumaili EK, et al. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009;24(1):117–22.
Cepoi V, et al. The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons. Int Urol Nephrol. 2012;44(1):213–20.
Singh NP, et al. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and modification of diet in renal disease equation: an observational, cross-sectional study. BMC Nephrol. 2009;10:4.
Gilbertson DT, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16(12):3736–41.
El Matri A, et al. Renal replacement therapy resources in Africa. Arab J Nephrol Transplant. 2008;1(1):9–14.
Abu-Aisha H, Elamin S. Peritoneal dialysis in Africa. Perit Dial Int. 2010;30(1):23–8.
Naicker S. End-stage renal disease in sub-Saharan Africa. Ethn Dis. 2009;19(1 Suppl 1):S1-13-5.
Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;354(10):997–9.
Lugon JR. End-stage renal disease and chronic kidney disease in Brazil. Ethn Dis. 2009;19(1 Suppl 1):S1-7-9.
Zatz R, Romao Jr JE. End-stage renal failure and national resources: the Brazilian experience. Ren Fail. 2006;28(8):627–9.
Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int. 2006;70(6):1107–14.
Jha V. End-stage renal care in developing countries: the India experience. Ren Fail. 2004;26(3):201–8.
White SL, et al. How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ. 2008;86(3):229–37.
US Renal Data System. USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2011. p. 2011.
Tsukamoto Y. End-stage renal disease (ESRD) and its treatment in Japan. Nephrol Dial Transplant. 2008;23(8):2447–50.
Cusumano A, et al. End-stage renal disease and its treatment in Latin America in the twenty-first century. Ren Fail. 2006;28(8):631–7.
ERA-EDTA Registry. ERA-EDTA registry annual report 2009. Amsterdam: Academic Medical Center, Department of Medical Informatics; 2011.
Dialysis and Transplantation Registration Group. The report about the registration of dialysis and transplantation in China 1999. Chin J Nephrol. 2001;17:77–8.
Yao Q, Zhang W, Qian J. Dialysis status in China: a report from the Shanghai Dialysis Registry (2000–2005). Ethn Dis. 2009;19(1 Suppl 1):S1-23-6.
Zuo L, Wang M. Current status of hemodialysis treatment in Beijing, China. Ethn Dis. 2006;16(2 Suppl 2):S2-31-4.
Zhang W, et al. Clinical characteristics and outcomes of rural patients with ESRD in Guangxi, China: one dialysis center experience. Int Urol Nephrol. 2010;42(1):195–204.
Grassmann A, et al. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20(12):2587–93.
Riella MC, Locatelli AJ. History of peritoneal dialysis in Latin America. Perit Dial Int. 2007;27(3):322–7.
Ho Y-W, et al. Hong Kong registry report 2004. Hong Kong J Nephrol. 2005;7(1):38–46.
Winkelmayer WC, et al. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002;22(5):417–30.
Fernandes N, et al. The Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD): characterization of the cohort. Kidney Int Suppl. 2008;108:S145–51.
Paniagua R, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307–20.
Just PM, et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant. 2008;23:2365–73.
Mahajan S, Tiwari S, Karla V, Bhowmik D, Agarwal S. Factors affecting the use of peritoneal dialysis among the ESRD population in India: a single-center study. Perit Dial Int. 2004;24(6):538–41.
Cruz DN, Troidle L, Danguilan R, Padilla B, Frando L, Sebastian E, Sy-Lim A, Luz V, Finkelstein F. Factors influencing dialysis modality for end-stage renal disease in developing countries: a survey of Filipino nephrologists. Blood Purif. 2011;32(2):117–23.
Fukuhara S, et al. The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ. 2007;7(2–3):217–31.
Shimazono Y. The state of the international organ trade: a provisional picture based on integration of available information. Bull World Health Organ. 2007;85(12):955–62.
Einollahi B, Taheri S. Renal transplantation practice in Iran and the Middle East: report from Iran and a review of the literature. Ann Transplant. 2008;13(1):5–14.
Medina-Pestana JO. Organization of a high-volume kidney transplant program—the “assembly line” approach. Transplantation. 2006;81(11):1510–20.
Foster P. China admits organs removed from prisoners for transplants. The Telegraph. 2009. London.
Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int Suppl. 2003;83:S115–8.
Rao M, et al. Haemodialysis for end-stage renal disease in Southern India—a perspective from a tertiary referral care centre. Nephrol Dial Transplant. 1998;13(10):2494–500.
Rizvi SA, et al. Renal transplantation in developing countries. Kidney Int Suppl. 2003;83:S96–100.
Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world—a growing challenge. N Engl J Med. 2007;356(3):213–5.
Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev. 1997;55(2):31–43.
Popkin BM. Using research on the obesity pandemic as a guide to a unified vision of nutrition. Public Health Nutr. 2005;8(6A):724–9.
Reardon T, et al. The rise of supermarkets in Africa, Asia, and Latin America. Am J Agr Econ. 2003;85(5):1140–6.
Chowdhury S, et al. The rise of supermarkets and vertical relationships in the Indonesian food value chain: causes and consequences. Asian J Agric Dev. 2005;2(1 & 2):30–48.
Monteiro CA, et al. Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ. 2004;82(12):940–6.
Lear SA, et al. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity (Silver Spring). 2007;15(11):2817–24.
Chandalia M, et al. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84(7):2329–35.
Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7(6):497–514.
Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27(10):2444–9.
Tillin T, et al. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and White Europeans: a UK population-based cross-sectional study. Diabetologia. 2005;48(4):649–56.
Oliveira MB, Romao Jr JE, Zatz R. End-stage renal disease in Brazil: epidemiology, prevention, and treatment. Kidney Int Suppl. 2005;97:S82–6.
Drukker A. Oligonephropathy: from a rare childhood disorder to a possible health problem in the adult. Isr Med Assoc J. 2002;4(3):191–5.
Li S, et al. Low birth weight is associated with chronic kidney disease only in men. Kidney Int. 2008;73(5):637–42.
White SL, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis. 2009;54(2):248–61.
Hoy WE, et al. Nephron number, hypertension, renal disease, and renal failure. J Am Soc Nephrol. 2005;16(9):2557–64.
Stettler N, et al. Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation. 2005;111(15):1897–903.
Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004;23(6 Suppl):588S–95.
Caballero B. A nutrition paradox—underweight and obesity in developing countries. N Engl J Med. 2005;352(15):1514–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Anand, S., Khanam, M.A., Finkelstein, F.O. (2014). Global Perspective of Kidney Disease. In: Byham-Gray, L., Burrowes, J., Chertow, G. (eds) Nutrition in Kidney Disease. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-685-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-685-6_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-684-9
Online ISBN: 978-1-62703-685-6
eBook Packages: MedicineMedicine (R0)